Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel [Phase 1]
A Phase 1 trial investigating tumor necrosis factor release in locally advanced breast cancer patients receiving neoadjuvant docetaxel has b…
-
CLINICAL_TRIALS withdrawal · 2014-03-05Clinical Trial Update: Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer [Phase 1]
A Phase 1 trial evaluating the combination of docetaxel, doxorubicin, and cyclophosphamide for advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-04Clinical Trial Update: Partial Breast Irradiation in a Low-risk Population Screened With MRI [NA]
A clinical trial evaluating partial breast irradiation in a low-risk breast cancer population screened with MRI has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery [Phase 2]
The Phase 2 trial of oral microencapsulated diindolylmethane for stage II-III triple-negative, androgen receptor-positive breast cancer afte…
-
CLINICAL_TRIALS withdrawal · 2014-02-06Clinical Trial Update: Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery [NA]
A clinical trial evaluating azacitidine for triple-negative breast cancer across stages I–IV and recurrent disease has been withdrawn (spons…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-02-06Clinical Trial Update: Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
A clinical trial evaluating culturally tailored information-based support groups for Chinese immigrants with breast cancer has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2014-02-04Clinical Trial Update: Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating systemic therapy with or without upfront surgery in metastatic breast cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-01-28Clinical Trial Update: Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer [NA]
The clinical trial evaluating vorinostat before surgery for Stage II/IIIA breast cancer, including triple-negative breast cancer, has been w…
-
EMA withdrawal · 2014-01-21EMA Lapsed: Docetaxel Teva Pharma (docetaxel) — Teva Pharma B.V.
The EMA lists Docetaxel Teva Pharma as lapsed (withdrawn) for multiple indications including non-small cell lung carcinoma, breast neoplasms…
-
CLINICAL_TRIALS withdrawal · 2013-12-24Clinical Trial Update: Prognostic Value of Stem Cell Related Markers
A clinical trial investigating the prognostic value of stem cell related markers in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating Abiraterone Acetate versus an Aromatase Inhibitor in postmenopausal ER-positive operable breast cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2013-12-05Clinical Trial Update: Deep Sequencing of the Breast Cancer Transcriptome
A clinical trial titled 'Deep Sequencing of the Breast Cancer Transcriptome' sponsored by the University of Arkansas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-20Clinical Trial Update: A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast [NA]
Clinical trial NCT00529334 investigating CyberKnife radiosurgery to the partial breast sponsored by Georgetown University has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2013-11-13Clinical Trial Update: S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Phase 3]
Phase 3 trial evaluating zoledronic acid or ibandronate to prevent bone problems in women with stage IV breast cancer that has spread to bon…
-
CLINICAL_TRIALS withdrawal · 2013-10-31Clinical Trial Update: Choline Quantification in Breast Cancer by MRS
The clinical trial on quantifying choline in breast cancer using magnetic resonance spectroscopy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-22Clinical Trial Update: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
A Phase III randomized trial comparing Mapisal to a urea hand-foot cream for preventing capecitabine-related hand-foot syndrome in patients …
-
CLINICAL_TRIALS withdrawal · 2013-10-08Clinical Trial Update: Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer [NA]
This clinical trial investigated using MRI apparent diffusion coefficient to predict response to neoadjuvant chemotherapy in breast cancer. …
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
Sanofi's open-label expanded-access protocol for iniparib in breast cancer is no longer available.
-
CLINICAL_TRIALS withdrawal · 2013-08-20Clinical Trial Update: MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer [Phase 1]
A Phase 1 trial of MK-2206 in combination with endocrine therapy for metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-20Clinical Trial Update: Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer [Phase 2]
Phase 2 trial of MK-2206 in combination with endocrine therapy for hormone receptor-positive metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]
Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer [NA]
A clinical trial evaluating biomarkers from fine-needle aspiration in women at increased or normal risk of breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Women With Advanced Breast Cancer [Phase 2]
Phase 2 trial of antineoplaston therapy for women with advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer [Phase 2]
A Phase 2 trial evaluating methotrexate with or without antineoplaston therapy for postmenopausal women with advanced refractory breast canc…
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant and adjuvant exemestane for postmenopausal women with locally advanced hormone receptor-positive brea…